Posted on January 29, 2007 by Albin Paul
Published by
1Institute for Medical Microbiology and Hygiene, Faculty of Medicine ‘Carl Gustav Carus’, Technical University of Dresden, Dresden and 2Clondiag Chip Technologies GmbH, Jena, Germany
ABSTRACT
This study evaluated a DNA oligonucleotide array that recognised 38 different Staphylococcus aureus targets, including all relevant resistance determinants and some toxins and species-specific controls. A new method for labelling sample [...]
Filed under: Clinical microarrays, Pharmacogenomics, bioinformatics, clinical diagnostics, drug discoverry, gene expression, genetics, genotyping, microarray analysis, microarray for clinical diagnostics, toxicogenomics | 1 Comment »
Posted on January 23, 2007 by Albin Paul
CAMBRIDGE, Mass. (January 21, 2007) — Autoimmune diseases such as type
1 diabetes, lupus and rheumatoid arthritis occur when the immune system
fails to regulate itself. But researchers have not known precisely
where the molecular breakdowns responsible for such failures occur.
Now, a team of scientists from the Whitehead Institute and the
Dana-Farber Cancer Institute have identified a key set [...]
Filed under: Clinical microarrays, clinical diagnostics, gene expression, genetics, genotyping, microarray | Leave a Comment »
Posted on January 22, 2007 by Albin Paul
Biotechnological methods can be used for cryptography. Here two different cryptographic approaches based on DNA binary strands are shown. The rst approach shows how DNA binary strands can be used for steganography to provide rapid encryption and decryption. It is shown that DNA steganogra- phy based on DNA binary strands is [...]
Filed under: DNA for cryptography, bioinformatics | Leave a Comment »
Posted on January 20, 2007 by Albin Paul
http://www.biologynews.net/archives/2006/12/19/gene_chip_technology_shows_potential_for_identifying_lifethreatening_blood_infection.html
Right now there’s no rapid way to diagnose sepsis, a fast-moving blood infection that is a leading cause of death in hospital intensive care units. The illness unleashes a powerful inflammatory response that can quickly overwhelm the body, causing organ failure and death, often within days.
New research now suggests that doctors one day could quickly [...]
Filed under: Clinical microarrays, Pharmacogenomics, clinical diagnostics, gene expression, genetics, genotyping, microarray, microarray for clinical diagnostics, toxicogenomics | Leave a Comment »
Posted on January 19, 2007 by Albin Paul
Source: Carnegie Mellon University December 2005
A standard Internet protocol that checks errors made during email transmissions has now inspired a revolutionary method to transform DNA microarray analysis, a common technology used to understand gene activation. The new method, which blends experiment and computation, strengthens DNA microarray analysis, according to its Carnegie Mellon University inventor, who has published [...]
Filed under: bioinformatis software, microarray, microarray analysis software, microarray software | Leave a Comment »
Posted on January 18, 2007 by Albin Paul
Its not a new topic IBM has discovered that it could use many of the pattern detection techniques and analysis used in bioinformatics in other fields as well.
I thought of adding this as bioinformatics is and microarrays are growing in popularity and decided to give few bytes such articles as wel.
Many of these studies are [...]
Filed under: Bioinformatics Techniques for spam detection, IBM, Spam analysis, bioinformatics, bioinformatics software, microarray software | 2 Comments »
Posted on January 12, 2007 by Albin Paul
I did a PhD and did NOT go mad
Before reading these wise words advising you how to do a PhD (inspired by three years of the author carefully and diligently banging his head on a table) you are requested to read and digest the following irony…
[...]
Filed under: Uncategorized | Leave a Comment »
Posted on January 12, 2007 by Albin Paul
source : http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1555602
Postmenopausal hormone-replacement therapy (HRT) increases breast-cancer risk. The influence of HRT on the biology of the primary tumor, however, is not well understood.
We obtained breast-cancer gene expression profiles using Affymetrix human genome U133A arrays. We examined the relationship between HRT-regulated gene profiles, tumor characteristics, and recurrence-free survival in 72 postmenopausal women.
Filed under: HRT, Hormone replacement and Genetics, Pharmacogenomics, SNP analysis, custom microarray, gene expression, genetics, genotyping, microarray | 1 Comment »
Posted on January 12, 2007 by Albin Paul
Source: http://www.medicalnewstoday.com/sections/genetics/
By fine-tuning “fine-needle aspiration” biopsies with a super-fast genetic microarray technology, a team of surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City says they can greatly enhance the accuracy of these tests.
“For patients with worrisome thyroid nodules, this means better information on whether the nodule is malignant or benign. That should [...]
Filed under: Pharmacogenomics, SNP analysis, bioinformatics, drug resistance, gene expression, genetics, genotyping, microarray, microarray for clinical diagnostics, toxicogenomics | 3 Comments »
Posted on January 12, 2007 by Albin Paul
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis. The US FDa has apprved use of two new microarrays for clinical decision making. The US Food and Drug Administration (FDA) encourages the development of new technologies such as microarrays which may improve and streamline assessments of safety and the effectiveness of medical [...]
Filed under: HRT, Hormone replacement and Genetics, Pharmacogenomics, SNP analysis, bioinformatics, custom microarray, drug development, drug discoverry, gene expression, genotyping, microarray, ocimum biosolutions, toxicogenomics, transgenomics | Leave a Comment »
Posted on January 10, 2007 by Albin Paul
One of the usage for microarrays could be to study how mutation works in microbes. The work might be helpful in unearthing more details about how bacteria acheive drug resistance. One of the current method is to subject the bacteria to stress (tempareature, drug and other environements) under varying conditions untill it shows resistance to [...]
Filed under: microarray | Leave a Comment »
Posted on January 9, 2007 by Albin Paul
Microarrays are finding more usage in drug discoverry and development process, toxicogenomics and pharmacogenomics studies have helped researchers to speed up the druug discovery to process, though it is still long way to produce any immediate effect to the patients. The use of toxicogenomics and comparative genomics studies can help scientists to unearth new therapeutic [...]
Filed under: Pharmacogenomics, bioinformatics, drug development, drug discoverry, microarray, toxicogenomics | Leave a Comment »